Tolmar In the News
Discover the latest in Tolmar’s mission towards
a healthier world.
a healthier world.
We’re proud of the work we do to bring scientific and clinical advancements to the world of pharmaceuticals. Check out the latest on how Tolmar is making a difference in our communities.
The pharma& Group Enters into an Exclusive Promotional Agreement with Tolmar, Inc. to Promote Rubraca® (rucaparib) in the U.S. for the Treatment of Metastatic Castration-Resistant Prostate Cancer
DelSiTech and Tolmar Announce Global License and Development Agreement
Tolmar Announces Acquisition of JATENZO® (testosterone undecanoate) for the Treatment of Hypogonadism to Expand its Market Leading Urology Portfolio
Eton Pharmaceuticals Announces Co-Promotion Agreement with Tolmar Pharmaceuticals for ALKINDI SPRINKLE®
Tolmar Establishes Tolmar Canada to Sell, Market and Distribute ELIGARD® in Canada
Centers for Medicare and Medicaid Services (CMS) Issues Permanent J-Code for Tolmar’s FENSOLVI® Effective July 1, 2021
Tolmar Launches “Little a Little Longer” Campaign: A Caregiver’s Guide to Central Precocious Puberty
Tolmar Publishes FENSOLVI® (leuprolide acetate) for Injectable Suspension Safety and Efficacy Data in Journal of Clinical Endocrinology and Metabolism
Articles & Announcements
We keep ourselves at the forefront of treatment and therapy advancements. Explore our innovative ideas and insights into the world of pharmaceuticals.